154 related articles for article (PubMed ID: 33807494)
1. Pretreatment MRI Radiomics Based Response Prediction Model in Locally Advanced Cervical Cancer.
Gui B; Autorino R; Miccò M; Nardangeli A; Pesce A; Lenkowicz J; Cusumano D; Russo L; Persiani S; Boldrini L; Dinapoli N; Macchia G; Sallustio G; Gambacorta MA; Ferrandina G; Manfredi R; Valentini V; Scambia G
Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33807494
[TBL] [Abstract][Full Text] [Related]
2. Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
Autorino R; Gui B; Panza G; Boldrini L; Cusumano D; Russo L; Nardangeli A; Persiani S; Campitelli M; Ferrandina G; Macchia G; Valentini V; Gambacorta MA; Manfredi R
Radiol Med; 2022 May; 127(5):498-506. PubMed ID: 35325372
[TBL] [Abstract][Full Text] [Related]
3. Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging radiomics: a multi-institutional study of the Japanese Radiation Oncology Study Group.
Ikushima H; Haga A; Ando K; Kato S; Kaneyasu Y; Uno T; Okonogi N; Yoshida K; Ariga T; Isohashi F; Harima Y; Kanemoto A; Ii N; Wakatsuki M; Ohno T
J Radiat Res; 2022 Jan; 63(1):98-106. PubMed ID: 34865079
[TBL] [Abstract][Full Text] [Related]
4. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
[TBL] [Abstract][Full Text] [Related]
5. Automated Prediction of Neoadjuvant Chemoradiotherapy Response in Locally Advanced Cervical Cancer Using Hybrid Model-Based MRI Radiomics.
Yang H; Xu Y; Dong M; Zhang Y; Gong J; Huang D; He J; Wei L; Huang S; Zhao L
Diagnostics (Basel); 2023 Dec; 14(1):. PubMed ID: 38201314
[TBL] [Abstract][Full Text] [Related]
6. Prediction of outcome using pretreatment
Lucia F; Visvikis D; Desseroit MC; Miranda O; Malhaire JP; Robin P; Pradier O; Hatt M; Schick U
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):768-786. PubMed ID: 29222685
[TBL] [Abstract][Full Text] [Related]
7. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
[TBL] [Abstract][Full Text] [Related]
8. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
[TBL] [Abstract][Full Text] [Related]
9. MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Yi X; Pei Q; Zhang Y; Zhu H; Wang Z; Chen C; Li Q; Long X; Tan F; Zhou Z; Liu W; Li C; Zhou Y; Song X; Li Y; Liao W; Li X; Sun L; Pei H; Zee C; Chen BT
Front Oncol; 2019; 9():552. PubMed ID: 31293979
[No Abstract] [Full Text] [Related]
10. Comparing deep learning and handcrafted radiomics to predict chemoradiotherapy response for locally advanced cervical cancer using pretreatment MRI.
Jeong S; Yu H; Park SH; Woo D; Lee SJ; Chong GO; Han HS; Kim JC
Sci Rep; 2024 Jan; 14(1):1180. PubMed ID: 38216687
[TBL] [Abstract][Full Text] [Related]
11. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
[TBL] [Abstract][Full Text] [Related]
12. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Liu Z; Zhang XY; Shi YJ; Wang L; Zhu HT; Tang Z; Wang S; Li XT; Tian J; Sun YS
Clin Cancer Res; 2017 Dec; 23(23):7253-7262. PubMed ID: 28939744
[No Abstract] [Full Text] [Related]
13. MRI-based radiomics of rectal cancer: preoperative assessment of the pathological features.
Ma X; Shen F; Jia Y; Xia Y; Li Q; Lu J
BMC Med Imaging; 2019 Nov; 19(1):86. PubMed ID: 31747902
[TBL] [Abstract][Full Text] [Related]
14. Can Pretreatment MRI and Planning CT Radiomics Improve Prediction of Complete Pathological Response in Locally Advanced Rectal Cancer Following Neoadjuvant Treatment?
Ramireddy JK; Sathya A; Sasidharan BK; Varghese AJ; Sathyamurthy A; John NO; Chandramohan A; Singh A; Joel A; Mittal R; Masih D; Varghese K; Rebekah G; Ram TS; Thomas HMT
J Gastrointest Cancer; 2024 Jun; ():. PubMed ID: 38856797
[TBL] [Abstract][Full Text] [Related]
15. Radiomics of MRI for the Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Single Referral Centre Analysis.
Pesapane F; Rotili A; Botta F; Raimondi S; Bianchini L; Corso F; Ferrari F; Penco S; Nicosia L; Bozzini A; Pizzamiglio M; Origgi D; Cremonesi M; Cassano E
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503081
[TBL] [Abstract][Full Text] [Related]
16. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.
Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D
Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192
[TBL] [Abstract][Full Text] [Related]
17. The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery.
Valentini AL; Miccò M; Gui B; Giuliani M; Rodolfino E; Telesca AM; Pasciuto T; Testa A; Gambacorta MA; Zannoni G; Rufini V; Giordano A; Valentini V; Scambia G; Manfredi R
Eur Radiol; 2018 Jun; 28(6):2425-2435. PubMed ID: 29318432
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
19. Utilization of radiomics to predict long-term outcome of magnetic resonance-guided focused ultrasound ablation therapy in adenomyosis.
Li Z; Zhang J; Song Y; Yin X; Chen A; Tang N; Prince MR; Yang G; Wang H
Eur Radiol; 2021 Jan; 31(1):392-402. PubMed ID: 32725335
[TBL] [Abstract][Full Text] [Related]
20. A field strength independent MR radiomics model to predict pathological complete response in locally advanced rectal cancer.
Cusumano D; Meijer G; Lenkowicz J; Chiloiro G; Boldrini L; Masciocchi C; Dinapoli N; Gatta R; Casà C; Damiani A; Barbaro B; Gambacorta MA; Azario L; De Spirito M; Intven M; Valentini V
Radiol Med; 2021 Mar; 126(3):421-429. PubMed ID: 32833198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
